FOPE, PharmaState Academy, complete one year of the PULSE program
Session 23 focused on Manufacturing under Loan License or Contract in light of the Revised Schedule M Guidelines
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
Sun Pharma’s phase 3 clinical studies evaluating ILUMYA in active psoriatic arthritis met their…
Treatment with tildrakizumab 100 mg (ILUMYA) resulted in greater improvements in PsA signs and symptoms at Week 24 compared to…
FDA approves 127 innovator and biosimilar drugs in 2024, marks shift in pharma approval landscape
According to GlobalData, the 2024 approvals included significant milestones in the biosimilar sector, with the FDA granting…
Venus Remedies secures WHO GDP endorsement for pharma logistics
Extending its reach directly to pharmacies and small retailers, Venus Remedies now operates a parallel online delivery system
Miltenyi Biotec and THSTI launch India’s first hands-on clinical cell manufacturing training…
The initiative aims to strengthen India’s cell and gene therapy capabilities through skill development and translational research…
CORONA Remedies acquires seven Bayer India brands to expand cardiology and women’s health portfolio
The acquisition marks CORONA Remedies' entry into the anti-platelet market and strengthens its position in India’s fertility and…
Lupin achieves GMP Certification from TGA Australia for dabhasa API facility
LMS offers pharma CDMO services and manufactures APIs
Asahi Kasei’s Microza Division earns EcoVadis gold rating for sustainability
Microza & Water Processing Division ranks in the top 5 per cent globally for sustainability performance, receiving high scores…
Danaher India and THSTI partner to strengthen biomanufacturing capabilities in India
On THSTI’s 16th Foundation Day, Danaher India and THSTI announce collaboration to enhance biomanufacturing skills, infrastructure,…
Despite global volatility India’s pharma exports continue to demonstrate steady resilience
Bhavin Mukund Mehta, Whole-Time Director at Kilitch Drugs and Vice-Chairman of Pharmexcil, discusses India’s pharma export…
Hengrui and Kailera report positive phase 3 results for dual GLP-1/GIP agonist in obesity treatment
HRS9531 achieves significant weight reduction in Phase 3 trial, with plans for NDA submission in China and global development as…
Emcure Pharmaceuticals and Sanofi India sign exclusive distribution agreement for oral anti-diabetic…
Partnership aims to improve access to Amaryl and Cetapin through Emcure’s distribution network, addressing rising diabetes burden…
Lupin launches Loteprednol Etabonate Ophthalmic Suspension, 0.5 per cent in the US
Loteprednol Etabonate Ophthalmic Suspension (RLD Lotemax) had estimated annual sales of $ 55 million in the US (IQVIA MAT May…
Biocon Biologics gains USFDA approval for Kirsty, Interchangeable Rapid-Acting Insulin Aspart
KIRSTY will be available as a single-patient-use prefilled pen for subcutaneous use and a multiple-dose vial for subcutaneous and…
Agilent launches InfinityLab Pro iQ Series mass detectors in India
The detectors manage workflows, including impurity profiling, biomolecule characterisation, trace-level detection, and mass-based…
Rethinking trust: what pharma can learn from Indian corner shops
Anagha Shirur - Adjunct Faculty, K J Somaiya Institute of Management, expresses how lessons from the kirana shops may offer…
Aspire Impact and Aspire Circle launch ESG Framework for Pharma & Healthcare
Framework unveiled in New Delhi by 15 co-authors, corporate and investment CXOs, from Cipla, Zydus, Sun Pharma, Quadria Capital,…
ViiV Healthcare, Medicines Patent Pool extend voluntary licensing to enable access to HIV treatment
Through the agreement, the existing licensees, Aurobindo, Cipla and Viatris, will be able to develop, manufacture and supply…
AATec Medical, Northway Biotech partner to develop industrial production process for ATL-105…
Lead indication is non-CF bronchiectasis; ATL-105 targets disease drivers through a broad multimodal mechanism of action
Indian pharma industry profitability improves as pricing environment eases: Equirus Capital
Trade generics and Jan Aushadhi are steadily gaining volume share from branded formulations, especially in price-sensitive acute…